Evofem Biosciences announces positive top-line results of phase 3 study evaluating Amphora for hormone-free birth control
December 2018
Click for full info +Full Info:
Resource Type:
Citation:
(2018, December 17). Evofem Biosciences.
Health Risks(s):
- STI / STD
- Unintended Pregnancy
Product type(s):
- Contraceptives
- Hormonal
- MPTs
- VaginalCream
Topic(s):
- MPTs
- Development
URL of resource: